|
|
Folic acid Vitamin B12* | |
|
Cranberry* | |
|
St. John's wort | |
| Supportive interaction |
None known |
| Adverse interaction |
None known |
An asterisk (*) next to an item in the summary indicates that the interaction is supported only by weak, fragmentary, and/or contradictory scientific evidence.
Folic acid
Folic acid is needed by the body to utilise vitamin B12.
Antacids, including omeprazole, inhibit folic acid absorption.1 People taking
antacids are advised to supplement with folic acid.
Vitamin B12
Omeprazole interferes with the absorption of vitamin B12 from food (though not from
supplements) in some2 3 4 5 but not
all6 7 studies. A true deficiency state, resulting in vitamin
B12-deficiency anaemia, has only been reported in one case.8 The fall in vitamin
B12 status may result from the decrease in stomach acid required for vitamin B12 absorption
from food caused by the drug.9 This problem may possibly be averted by drinking
acidic juices when eating foods containing vitamin B12.10
However, all people taking omeprazole need to either supplement with vitamin B12 or have their vitamin B12 status checked on a yearly basis. Even relatively small amounts of vitamin B12 such as 10–50 mcg per day, are likely to protect against drug induced vitamin depletion.
St. John's
wort
In a study of healthy human volunteers, supplementing with St. John's wort greatly decreased
omeprazole blood levels by accelerating the metabolism of the drug.11 Use of St.
John's wort may, therefore, interfere with the actions of omeprazole.
Cranberry (Vaccinium
marocarpon)
People taking omeprazole may increase absorption of dietary vitamin B12 by drinking cranberry
juice or other acidic liquids with vitamin B12-containing foods.12
1. Russell RM, Golner BB, Krasinski SD, et al. Effect of antacid and H2 receptor antagonists on the intestinal absorption of folic acid. J Lab Clin Med 1988;112:458–63.
2. Marcuard SP, Albernaz L, Khazanie PG. Omeprazole therapy causes malabsorption of cyanocobalamin (Vitamin B12). Ann Intern Med 1994;120:211–5.
3. Termanini B, Gibril F, Sutliff VE, et al. Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome. Am J Med 1998;104:422–30.
4. Koop H. Review article: metabolic consequences of long-term inhibition of acid secretion by omeprazole. Aliment Pharmacol Ther 1992;6:399–406 [review].
5. Bellou A, Aimone-Gastin I, De Korwin JD, et al. Cobalamin deficiency with megaloblastic anaemia in one patient under long-term omeprazole therapy. J Intern Med 1996;240:161–4.
6. Koop H, Bachem MG. Serum iron, ferritin, and vitamin B12 during prolonged omeprazole therapy. J Clin Gastroenterol 1992;14:288–92.
7. Schenk BE, Festen HP, Kuipers EJ, et al. Effect of short-and long-term treatment with omeprazole on the absorption and serum levels of cobalamin. Aliment Pharmacol Ther 1996;10:541–5.
8. Bellou A, Aimone-Gastin I, De Korwin JD, et al. Cobalamin deficiency with megaloblastic anaemia in one patient under long-term omeprazole therapy. J Intern Med 1996;240:161–4.
9. Saltzman JR, Kemp JA, Golner BB, et al. Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-bound vitamin B12 absorption. J Am Coll Nutr 1994;13:584–91.
10. Bradford GS, Taylor CT. Omeprazole and vitamin B12 deficiency. Ann Pharmacother 1999;33:641–3 [review].
11. Wang LS, Zhou G, Zhu B, et al. St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole. Clin Pharmacol Ther 2004;75:191–7.
12. Saltzman JR, Kemp JA, Golner BB, et al. Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-bound vitamin B12 absorption. J Am Coll Nutr 1994;13:584–91.
| |||||||